Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

ConclusionsDOACs can be safely administered to patients with brain tumors. In patients with primary brain tumors (i.e. glioma), DOACs appear to be safer than LMWH and should be considered for this indication.Figure.DisclosuresZwicker: Incyte: Research Funding; Parexel: Consultancy; Quercegen: Research Funding; Daiichi: Honoraria.

Source: Blood - November 21, 2018 Category: Hematology Authors: Carney, B. J., Uhlmann, E. J., Puligandla, M., Mantia, C., Weber, G. M., Neuberg, D. S., Zwicker, J. I. Tags: 332. Antithrombotic Therapy: Poster II Source Type: research